Systemic sclerosis & Raynaud's

Identification of Risk Factors for Incident Left Ventricular Systolic Dysfunction and Predictors of Cardiac Recovery in Patients With Systemic Sclerosis

Arthritis RheumatolPublished Retrospective cohort study

Authors' conclusion

Distinct demographic SSc-specific and cardiac characteristics are associated with increased risk of incident LVSD in SSc, with skeletal myopathy and anti-Ku antibodies being important risk factors for severe disease. Some patients improved, which was more likely in anti-RNAP III positive patients.

Study context

Population
Patients with Systemic Sclerosis (SSc) in the Johns Hopkins Scleroderma Center Research Registry
Participants
2,303 patients13,209 echocardiograms
Outcome
Incident LVSD (EF ≥50% declining to <50%; EF >35% dropping to ≤35% [severe LVSD]) and cardiac recovery
Methodological detailsregistry-based, multivariate logistic regression with time-varying and invariant variables, random forest analysis
  • Registry-based
  • Multivariate logistic regression with time-varying and invariant variables
  • Random forest analysis

Main finding

As reported in the abstract

  • Incident left ventricular systolic dysfunction (LVSD) (ejection fraction (EF) < 50%): male sex, Black race, diffuse skin disease, higher modified Rodnan skin score (mRSS), echocardiographic pulmonary hypertension (PH), kidney disease and AF associated with increased odds; anticentromere and anti-topoisomerase-1 protective
  • Incident severe LVSD (EF ≤ 35%): male sex, higher mRSS, PH, skeletal myopathy, kidney disease, AF and anti-Ku antibodies associated with higher odds
  • Recovery after previous EF <50%: tendon friction rubs associated with lower odds, anti-RNA polymerase III with higher odds
  • Recovery to EF >35% after previous EF ≤35%: diabetes associated with lower odds

Observational data: associations, not effects.

Original publication

Identification of Risk Factors for Incident Left Ventricular Systolic Dysfunction and Predictors of Cardiac Recovery in Patients With Systemic Sclerosis. Arthritis Rheumatol. Published 4 January 2026. doi:10.1002/art.43408

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.